Intelligence Platform
Patents
Browse 64 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12378248
A1 adenosine receptor agonists and methods of use thereof
granted patentUS 12325708
Adenosine 2 receptor antagonists
granted patentUS 12310965
Treatment of cancer utilizing an identified adenosine fingerprint
granted patentUS 12213990
A3 adenosine receptor ligand for use for achieving a fat loss effect
granted patentUS 12174192
Methods for detecting and treating cancers having adenosine pathway activation
granted patentUS 12168023
Inhibitors of adenosine 5′-nucleotidase
granted patentUS 12116635
Methods for detecting and treating cancers having adenosine pathway activation
granted patentUS 11795443
Uses of adenosine base editors
granted patentUS 11591579
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
granted patentUS 11584923
Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
granted patentUS 11471528
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to
granted patentUS 11396647
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
granted patentUS 11254686
Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor
granted patentUS 11246871
Targeting adenosine A2A receptors for the treatment of levodopa-induced dyskinesias
granted patentUS 11155803
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a tar
granted patentUS 11118167
Enzyme-mediated depletion of adenosine and/or methylthioadenosine
granted patentUS 11058704
Inhibitors of adenosine 5′-nucleotidase
granted patentUS 11040091
Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods fo
granted patentUS 10583180
Method for treating adenosine deaminase severe combined imunodeficiency
granted patentUS 10577368
A3 adenosine receptor agonists
granted patentUS 10376515
Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activati
granted patentUS 10314908
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to
granted patentUS 10265337
Use of A3 adenosine receptor agonist in osteoarthritis treatment
granted patentUS 10016432
Methanocarba derivatives of pseudoribose that inhibit adenosine kinase
granted